Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cellline xenografted into nude mice
I. Chatzistamou et al., Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cellline xenografted into nude mice, J CLIN END, 86(5), 2001, pp. 2144-2152
The effects of antagonists of GHRH and the somatostatin analog RC-160 on th
e growth of OV-1063 human epithelial ovarian cancer cells xenografted into
nude mice were investigated. Treatment with 20 mug/day of the GHRH antagoni
st JV-1-36 or MZ-5-156 and 60 mug/day of the somatostatin analog RC-160 for
25 days decreased tumor volume by 70.9% (P < 0.01), 58.3% (P < 0.05), and
60.6% (P < 0.01), respectively, us, the control value. The levels of GH in
serum were decreased in all of the treated groups, but only RC-160 signific
antly reduced serum insulin-like growth factor I (IGF-I). The levels of mes
senger ribonucleic acid (mRNA) for IGF-I and -II and for their receptors in
OV-1063 tumors were investigated by multiplex RT-PCR. No expression of mRN
A for IGF I was detected, but treatment with JV-1-136 caused a 51.8% decrea
se (P < 0.05) in the level of mRNA for IGF-II in tumors. Exposure of OV-106
3 cells cultured in vitro to GHRH, IGF-I, or IGF-II significantly (P < 0.05
) stimulated cell growth, but 10(-5) mol/L JV-1-36 nearly completely inhibi
ted (P < 0.001) OV-1063 cell proliferation. OV-1063 tumors expressed mRNA f
or GHRH receptors and showed the presence of binding sites for GHRH. Our re
sults indicate that antagonistic analogs of GHRH and the somatostatin analo
g RC-160 inhibit the growth of epithelial ovarian cancers. The effects of R
C-160 seem to be exerted more on the pituitary GH-hepatic IGF-I axis, where
as GHRH antagonists appear to reduce IGF-II production and interfere with t
he autocrine regulatory pathway. The antitumorigenic action of GHRH antagon
ists appears to be mediated by GHRH receptors found in OV-1063 tumors.